Medications

New cancer inhibitor effective where others fail

A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University ...

Medical research

Target found to arrest cancer growth

Adelaide researchers are homing in on a new treatment target for the aggressive blood cancer multiple myeloma.

page 1 from 15